Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
As a new crypto investor, it's crucial to know what to watch out for to avoid costly mistakes. Equip yourself with knowledge to navigate the market safely.
27,825 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Mega IPOs grab headlines and spark fears of a market crash. This article breaks down the data, weighs the odds, and s...
Oasis Management revealed a sizable new stake in Vail Resorts, boosting its position by 237,162 shares in Q1. This ar...
A new wave could lift fix-and-flip and BRRRR strategies in 2026. This guide shows how excited investors—home flipping...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
Robinhood stock has shown volatility as July 29 earnings approach. This guide breaks down what matters, how to read t...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Celsius investors are watching how 2025 earnings unfold as the company scales international growth, expands product l...
A week of trouble tested Amazon's operations and investor nerves. This article breaks down two essential takeaways an...
Rising defense budgets are reshaping the investing landscape. This guide explains why two big players may benefit and...